List of Figures
Figure 1: Number of Products under Development for Thalassemia
Figure 2: Number of Products under Development by Companies, Thalassemia
Figure 3: Number of Products under Development by Universities/Institutes, Thalassemia
Figure 4: Number of Products under Development for Hemophilia B
Figure 5: Number of Products under Development by Companies, Hemophilia B
Figure 6: Number of Products under Development by Universities/Institutes, Hemophilia B
Figure 7: Number of Products under Development for Sickle Cell Disease
Figure 8: Number of Products under Development by Companies, Sickle Cell Disease
Figure 9: Number of Products under Development by Universities/Institutes, Sickle Cell Disease
Figure 10: Number of Products by Top 10 Targets, Thalassemia
Figure 11: Number of Products by Stage and Top 10 Targets, Thalassemia
Figure 12: Number of Products by Top 10 Mechanism of Actions, Thalassemia
Figure 13: Number of Products by Stage and Top 10 Mechanism of Actions, Thalassemia
Figure 14: Number of Products by Routes of Administration, Thalassemia
Figure 15: Number of Products by Stage and Routes of Administration, Thalassemia
Figure 16: Number of Products by Molecule Types, Thalassemia
Figure 17: Number of Products by Stage and Molecule Types, Thalassemia
Figure 18: Number of Products by Targets, Hemophilia B
Figure 19: Number of Products by Stage and Targets, Hemophilia B
Figure 20: Number of Products by Mechanism of Actions, Hemophilia B
Figure 21: Number of Products by Stage and Mechanism of Actions, Hemophilia B
Figure 22: Number of Products by Routes of Administration, Hemophilia B
Figure 23: Number of Products by Stage and Routes of Administration, Hemophilia B
Figure 24: Number of Products by Molecule Types, Hemophilia B
Figure 25: Number of Products by Stage and Molecule Types, Hemophilia B
Figure 26: Number of Products by Top 10 Targets, Sickle Cell Disease
Figure 27: Number of Products by Stage and Top 10 Targets, Sickle Cell Disease
Figure 28: Number of Products by Top 10 Mechanism of Actions, Sickle Cell Disease
Figure 29: Number of Products by Stage and Top 10 Mechanism of Actions, Sickle Cell Disease
Figure 30: Number of Products by Routes of Administration, Sickle Cell Disease
Figure 31: Number of Products by Stage and Routes of Administration, Sickle Cell Disease
Figure 32: Number of Products by Top 10 Molecule Types, Sickle Cell Disease
Figure 33: Number of Products by Stage and Top 10 Molecule Types, Sickle Cell Disease